New Risk • Jul 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). Earnings have declined by 74% per year over the past 5 years. Market cap is less than US$10m (₹331.6m market cap, or US$3.50m). Minor Risk Revenue is less than US$5m (₹124m revenue, or US$1.3m).
Reported Earnings • May 23Full year 2026 earnings released: ₹2.44 loss per share (vs ₹0.46 loss in FY 2025)Full year 2026 results: ₹2.44 loss per share (further deteriorated from ₹0.46 loss in FY 2025). Revenue: ₹206.6m (down 19% from FY 2025). Net loss: ₹30.4m (loss widened 432% from FY 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance.
Announcement • May 14Medi-Caps Limited to Report Q4, 2026 Results on May 21, 2026Medi-Caps Limited announced that they will report Q4, 2026 results on May 21, 2026